Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Covington
Cipla
Citi
Fish and Richardson
Express Scripts
Accenture
Cantor Fitzgerald
Harvard Business School

Generated: July 17, 2018

DrugPatentWatch Database Preview

Jubilant Generics Company Profile

« Back to Dashboard

What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?

JUBILANT GENERICS has thirty-nine approved drugs.



Summary for Jubilant Generics
US Patents:0
Tradenames:35
Ingredients:34
NDAs:39
Patent Litigation for Jubilant Generics: See patent lawsuits for Jubilant Generics

Drugs and US Patents for Jubilant Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207450-001 May 15, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Jubilant Generics CELECOXIB celecoxib CAPSULE;ORAL 207061-001 Apr 4, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Jubilant Generics FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 203983-002 Aug 19, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Jubilant Generics PAROXETINE HYDROCHLORIDE paroxetine hydrochloride TABLET;ORAL 205528-002 Nov 27, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
Federal Trade Commission
Fish and Richardson
Express Scripts
QuintilesIMS
Cipla
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.